Krishna_Chatterjee

Krishna Chatterjee

Krishna Chatterjee

British endocrinologist (born 1958)

Vengalil Krishna Kumar Chatterjee CBE FRS FRCP FMedSci[2] (born 23 April 1958)[1] is a British endocrinologist. He is a professor of endocrinology in the Department of Medicine at the University of Cambridge[3] and a fellow of Churchill College, Cambridge.[4] He is also the director of the Cambridge Clinical Research Centre, part of the National Institute for Health Research (NIHR).[5]

Quick Facts Born, Alma mater ...

Education

Chatterjee was born on 23 April 1958. He was educated at Wolfson College, Oxford, where he was awarded a Bachelor of Arts degree, and a Bachelor of Medicine, Bachelor of Surgery degree in 1982.[1][6]

Research and career

Chatterjee is distinguished for his discoveries of genetic disorders of thyroid gland formation, regulation of hormone synthesis and hormone action, which have advanced fundamental knowledge of the hypothalamic–pituitary–thyroid axis.[2] He has identified dominant negative inhibition by defective nuclear receptors as a common mechanism in thyroid hormone resistance and peroxisome proliferator-activated receptor gamma (PPARγ)-mediated insulin resistance.[2][7] He has shown how deficiency of human selenocysteine-containing proteins causes a multisystem disease, including disordered thyroid hormone metabolism. He seeks to translate such understanding into better diagnosis and therapy of both rare and common thyroid conditions.[2]

Notable Cambridge scientists with whom Chatterjee has shared paper authorship include Sadaf Farooqi, Stephen O'Rahilly, Antonio Vidal-Puig, and Nick Wareham.

Chatterjee was appointed Commander of the Order of the British Empire (CBE) in the 2023 New Year Honours for services to people with endocrine disorders.[8]

References

  1. [1]
    "Chatterjee, Prof. (Vengalil) Krishna (Kumar)". Who's Who. A & C Black. 2020. doi:10.1093/ww/9780199540884.013.U10709. (Subscription or UK public library membership required.)
  2. [2]
    Anon (2017). "Professor Krishna Chatterjee FMedSci FRS". royalsociety.org. London: Royal Society. One or more of the preceding sentences incorporates text from the royalsociety.org website where:
    “All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --"Royal Society Terms, conditions and policies". Archived from the original on 2016-11-11. Retrieved 2016-03-09.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  3. [3]
    Krishna Chatterjee publications indexed by the Scopus bibliographic database. (subscription required)
  4. [4]
    "Professor Krishna Chatterjee". chu.cam.ac.uk. Archived from the original on 2017-08-11.
  5. [5]
    "Krishna Chatterjee". Wellcome-MRC Institute of Metabolic Science. Retrieved 2022-02-09.
  6. [6]
    "ORCID". orcid.org. Retrieved 2022-02-09.
  7. [7]
    O'Rahilly, S.; Barroso, I.; Gurnell, M.; Crowley, V. E. F.; Agostini, M.; Schwabe, J. W.; Soos, M. A.; Maslen, G. LI; Williams, T. D. M.; Lewis, H.; Schafer, A. J.; Chatterjee, V. K. K. (1999). "Dominant negative mutations in human PPARbig gamma associated with severe insulin resistance, diabetes mellitus and hypertension". Nature. 402 (6764): 880–883. Bibcode:1999Natur.402..880B. doi:10.1038/47254. ISSN 0028-0836. PMID 10622252. S2CID 4423555. (subscription required)
  8. [8]
    "No. 63918". The London Gazette (Supplement). 31 December 2022. p. N9.
Stub icon

This article about a British scientist is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Krishna_Chatterjee, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.